AdvaMed CEO Scott Whitaker Talks Mid-Terms, Device Tax and Innovative Programs for Smaller Companies
Nov 20, 2018•36 min•Ep. 119
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Scott Whitaker, the CEO of AdvaMed, has worked in DC for close to two decades. So naturally, we asked him for his take on what the outcome of the midterm elections means for Medtech. Does it improve chances for the repeal of the Medical Device tax? We also talked about what AdvaMed is doing to entice smaller medtechs to join.
For the best experience, listen in Metacast app for iOS or Android